Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3078572 | 1.00 | LMNA (0.31) | LMNA | |
| SCHEMBL691829 | 1.00 | LMNA (0.31) | LMNA | |
| SCHEMBL8568873 | 0.86 | — | — | |
| SCHEMBL9770136 | 0.80 | LMNA (0.33) | LMNA | |
| SCHEMBL2830039 | 0.80 | LMNA (0.33) | LMNA | |
| SCHEMBL9776465 | 0.80 | LMNA (0.33) | LMNA | |
| SCHEMBL29242570 | 0.80 | LMNA (0.33) | LMNA | |
| SCHEMBL1471245 | 0.80 | LMNA (0.33) | LMNA | |
| SCHEMBL6744722 | 0.80 | LMNA (0.33) | LMNA | |
| SCHEMBL1463092 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210139441-A1 | USES OF FLUORINATED EPOXIDES AND NOVEL MIXTURES THEREOF | THE CHEMOURS COMPANY FC, LLC (US) | 2021-05-13 | — | — | US | claimed |
| WO-2018165608-A1 | PROCESSES FOR PREPARING PARTIALLY FLUORINATED EPOXIDES AND PERFLUORINATED EPOXIDES AND COMPOSITIONS RELATED THERETO | THE CHEMOURS COMPANY FC, LLC (US) | 2018-09-13 | — | — | WO | claimed |
| WO-2018165623-A1 | USES OF FLUORINATED EPOXIDES AND NOVEL MIXTURES THEREOF | THE CHEMOURS COMPANY FC, LLC (US) | 2018-09-13 | — | — | WO | claimed |
| EP-3668937-B1 | COMPOSITIONS AND USES OF Z-1-CHLORO-2,3,3,3-TETRAFLUOROPROP-1-ENE | CHEMOURS CO FC LLC (US) | 2023-05-03 | — | — | EP | disclosed |
| US-20210139441-A1 | USES OF FLUORINATED EPOXIDES AND NOVEL MIXTURES THEREOF | THE CHEMOURS COMPANY FC, LLC (US) | 2021-05-13 | — | — | US | disclosed |
| US-20210139441-A1 | USES OF FLUORINATED EPOXIDES AND NOVEL MIXTURES THEREOF | THE CHEMOURS COMPANY FC, LLC (US) | 2021-05-13 | — | — | US | disclosed |
| WO-2018165623-A1 | USES OF FLUORINATED EPOXIDES AND NOVEL MIXTURES THEREOF | THE CHEMOURS COMPANY FC, LLC (US) | 2018-09-13 | — | — | WO | disclosed |
| WO-2018165608-A1 | PROCESSES FOR PREPARING PARTIALLY FLUORINATED EPOXIDES AND PERFLUORINATED EPOXIDES AND COMPOSITIONS RELATED THERETO | THE CHEMOURS COMPANY FC, LLC (US) | 2018-09-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210139441-A1 | USES OF FLUORINATED EPOXIDES AND NOVEL MIXTURES THEREOF | PFAS, PFN1, FRG1 | LMNA 3631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.